Tempus acquires oncology research company
San Francisco-based Highline Sciences will help Tempus expand its clinical trials business.
Source: chicagobusiness.com
Stay updated with breaking news from Highline Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
San Francisco-based Highline Sciences will help Tempus expand its clinical trials business.
The acquisition will allow Tempus to vertically integrate more clinical trial services into its CRO partnerships.